199 related articles for article (PubMed ID: 4609352)
1. Active immunotherapy in spontaneous leukemia of AkR mice.
Mathé G; Halle-Pannenko O; Bourut C
Exp Hematol; 1973; 1(2):110-4. PubMed ID: 4609352
[No Abstract] [Full Text] [Related]
2. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
Bekesi JG; Roboz JP; Zimmerman E; Holland JF
Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
[TBL] [Abstract][Full Text] [Related]
3. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
[No Abstract] [Full Text] [Related]
4. Immunotherapy with neuraminidase-treated cells and bacillus Calmette-Guerin.
Kollmorgen GM; Killion JJ; Sansing WA; Cantrell JL; Bundren JC; LeFever AV
Surgery; 1976 Feb; 79(02):202-8. PubMed ID: 1108258
[TBL] [Abstract][Full Text] [Related]
5. Letter: Routes other than I.V. injection to mice for BCG administration in active immunotherapy of L1210 leukemia.
Martin M; Bourut C; Halle-Pannenko O; Mathé
Biomedicine; 1975 Oct; 23(8):339-40. PubMed ID: 1231929
[No Abstract] [Full Text] [Related]
6. Correlations between humoral immunity and successful chemotherapy-immunotherapy.
Cantrell JL; Killion JJ; Kollmorgen GM
Cancer Res; 1976 Sep; 36(9 pt.1):3051-7. PubMed ID: 788896
[TBL] [Abstract][Full Text] [Related]
7. Acute myelocytic leukemia.
Holland JF; Glidewell O; Ellison RR; Corey RW; Schwartz J; Wallace HJ; Hoagland HC; Wiernik P; Rai K; Bekesi JG; Cuttner J
Arch Intern Med; 1976 Dec; 136(12):1377-81. PubMed ID: 793552
[No Abstract] [Full Text] [Related]
8. Active immunotherapy of AkR mice spontaneous leukemia.
Mathé G; Halle-Pannenko O; Bourut C
Rev Eur Etud Clin Biol; 1972 Dec; 17(10):997-1000. PubMed ID: 4660002
[No Abstract] [Full Text] [Related]
9. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
[No Abstract] [Full Text] [Related]
10. Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemia.
Mathé G; Halle-Pannenko O; Bourut C
Eur J Cancer (1965); 1974 Oct; 10(10):661-6. PubMed ID: 4465103
[No Abstract] [Full Text] [Related]
11. [Active immunotherapy of L 1210 leukemia given after the graft of the tumor].
Mathé G
Rev Fr Etud Clin Biol; 1968 Nov; 13(9):881-3. PubMed ID: 5304470
[No Abstract] [Full Text] [Related]
12. Comparison between the effects of Micrococcus, BCG and related polysaccharides in preclinical chemo-immunotherapy of murine L 1210 leukaemia [proceedings].
Verloes R; Atassi G; Dumont P; Kanarek L
Arch Int Physiol Biochim; 1978 Oct; 86(4):969-71. PubMed ID: 84653
[No Abstract] [Full Text] [Related]
13. [Experiments in the immunization of hybrid F1 mice against leukemia L1210].
Brambilla G; Cavanna M; Parodi S; Baldini L
Arch Ital Patol Clin Tumori; 1968; 11(3):253-61. PubMed ID: 5737806
[No Abstract] [Full Text] [Related]
14. Comparison of Micrococcus, BCG and related polysaccharides in the specific and non-specific immune resistance to murine L1210 leukemia [proceedings].
Verloes R; Atassi G; Dumont P; Kanarek L
Arch Int Physiol Biochim; 1978 May; 86(2):466-8. PubMed ID: 81034
[No Abstract] [Full Text] [Related]
15. Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.
Bortin MM; Rimm AA; Rodey GE; Giller R; Saltzstein EC
Cancer Res; 1974 Aug; 34(8):1851-6. PubMed ID: 4152270
[No Abstract] [Full Text] [Related]
16. Active specific immunotherapy for acute myelogenous leukaemia.
Powles R
Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
[No Abstract] [Full Text] [Related]
17. Induction of transplantation resistance to murine L1210 leukemia cells in BCG-primed mice by immunization with tuberculin protein-coupled L1210 cells.
Ohno R; Kodera Y; Ogura M; Yamada H
Gan; 1984 Feb; 75(2):187-92. PubMed ID: 6428959
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of leukaemia.
Malpas JS
Schweiz Med Wochenschr; 1974 May; 104(18):626-33. PubMed ID: 4596725
[No Abstract] [Full Text] [Related]
19. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
Murahata RI; Mitchell MS
J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents.
Kataoka T; Kobayashi H; Sakurai Y
Cancer Res; 1978 May; 38(5):1202-7. PubMed ID: 639053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
